Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Head & Neck 1Breast 1

Conditions

Head and Neck Neoplasms 1869Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 518Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Neoplasms 187Carcinoma, Squamous Cell 187Breast Neoplasms 183Lung Neoplasms 181Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 112Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 86Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dihydropyrimidine Dehydrogenase Deficiency × Head & Neck × Clear all
NCT04541381 2026-05-07

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

University of Chicago

Phase NA Suspended
860 enrolled
BreastGastrointestinalHead & Neck

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Dihydropyrimidine Dehydrogenase Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡